Literature DB >> 15611080

Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling.

Colin A Syme1, Peter A Friedman, Alessandro Bisello.   

Abstract

Agonist-mediated activation of the type 1 parathyroid hormone receptor (PTH1R) results in several signaling events and receptor endocytosis. It is well documented that arrestins contribute to desensitization of both G(s)- and G(q)-mediated signaling and mediate PTH1R internalization. However, whether PTH1R trafficking directly contributes to signaling remains unclear. To address this question, we investigated the role of PTH1R trafficking in cAMP signaling and activation of extracellular signal-regulated kinases ERK1/2 in HEK-293 cells. Dominant negative forms of dynamin (K44A-dynamin) and beta-arrestin1 (beta-arrestin1-(319-418)) abrogated PTH1R internalization but had no effect on cAMP signaling; neither acute cAMP production by PTH nor desensitization and resensitization of cAMP signaling were affected. Therefore, PTH1R trafficking is not necessary for regulation of cAMP signaling. PTH-(1-34) induced rapid and robust activation of ERK1/2. A PTHrP-based analog ([p-benzoylphenylalanine1, Ile5,Arg(11,13),Tyr36]PTHrP-(1-36)NH2), which selectively activates the G(s)/cAMP pathway without inducing PTH1R endocytosis, failed to stimulate ERK1/2 activity. Inhibition of PTH1R endocytosis by K44A-dynamin dampened ERK1/2 activation in response to PTH-(1-34) by 69%. Incubation with the epidermal growth factor receptor inhibitor AG1478 reduced ERK1/2 phosphorylation further. In addition, ERK1/2 phosphorylation occurred following internalization of a PTH1R mutant induced by PTH-(7-34) in the absence of G protein signaling. Collectively, these data indicate that PTH1R trafficking and G(q) (but not G(s)) signaling independently contribute to ERK1/2 activation, predominantly via transactivation of the epidermal growth factor receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611080     DOI: 10.1074/jbc.M413393200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Connexin43 interacts with βarrestin: a pre-requisite for osteoblast survival induced by parathyroid hormone.

Authors:  Nicoletta Bivi; Virginia Lezcano; Milena Romanello; Teresita Bellido; Lilian I Plotkin
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

2.  Disruption of parathyroid hormone and parathyroid hormone-related peptide receptor phosphorylation prolongs ERK1/2 MAPK activation and enhances c-fos expression.

Authors:  Hesham A Tawfeek; Abdul B Abou-Samra
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-13       Impact factor: 4.310

3.  Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.

Authors:  Yanmei Yang; Bin Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-06-03       Impact factor: 3.575

4.  Site-specific polyubiquitination differentially regulates parathyroid hormone receptor-initiated MAPK signaling and cell proliferation.

Authors:  Qiangmin Zhang; Kunhong Xiao; Hongda Liu; Lei Song; Jennifer C McGarvey; W Bruce Sneddon; Alessandro Bisello; Peter A Friedman
Journal:  J Biol Chem       Date:  2018-02-14       Impact factor: 5.157

5.  Parathyroid hormone-related protein promotes epithelial-mesenchymal transition.

Authors:  Juan Antonio Ardura; Sandra Rayego-Mateos; David Rámila; Marta Ruiz-Ortega; Pedro Esbrit
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

6.  Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway.

Authors:  Bin Wang; Yanmei Yang; Peter A Friedman
Journal:  Mol Biol Cell       Date:  2008-02-13       Impact factor: 4.138

7.  Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.

Authors:  Sébastien Ferrandon; Timothy N Feinstein; Marian Castro; Bin Wang; Richard Bouley; John T Potts; Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Nat Chem Biol       Date:  2009-08-23       Impact factor: 15.040

8.  Endogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells.

Authors:  Gyun Jee Song; Nathalie Fiaschi-Taesch; Alessandro Bisello
Journal:  Mol Endocrinol       Date:  2009-07-02

9.  Eliminating phosphorylation sites of the parathyroid hormone receptor type 1 differentially affects stimulation of phospholipase C and receptor internalization.

Authors:  Susanne U Miedlich; Abdul B Abou-Samra
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

Review 10.  PTH receptor-1 signalling-mechanistic insights and therapeutic prospects.

Authors:  Ross W Cheloha; Samuel H Gellman; Jean-Pierre Vilardaga; Thomas J Gardella
Journal:  Nat Rev Endocrinol       Date:  2015-08-25       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.